A man fainted in the Oval Office on Thursday. The incident occurred during a major presidential announcement. President Donald Trump was hosting executives from top pharmaceutical companies.
The event was quickly suspended. Video of the collapse spread rapidly online. The individual’s condition prompted immediate concern and a company clarification.
Clarification from Novo Nordisk Amid Misidentification Buzz
Initial online reports identified the man as Gordon Findlay. He was wrongly named as a Novo Nordisk executive. This claim gained traction on social media platforms.
Novo Nordisk promptly addressed the speculation. According to Newsweek, the company stated only two of its representatives were present. They were CEO Mike Doustdar and EVP Dave Moore.
The company extended well wishes to the unidentified gentleman. The White House Medical Unit responded to the scene. Press Secretary Karoline Leavitt confirmed the individual was okay.
Broader Impact on Policy Announcement and Public Discourse
The press conference was detailing a significant healthcare deal. The agreement involved Eli Lilly and Novo Nordisk. It aimed to lower prices for obesity drugs like Zepbound and Wegovy.
The unexpected medical event overshadowed the policy news momentarily. It shifted public attention to the human incident. According to Reuters, such events are rare during official Oval Office briefings.
The episode highlighted the intense pressure of high-stakes Washington events. It also demonstrated the swift response of White House medical staff. The meeting resumed after the situation was stabilized.
The Oval Office medical emergency provided a stark, human moment during a formal policy rollout, reminding all of the unpredictability of live events.
Info at your fingertips
What was happening when the person fainted?
President Trump was announcing a deal with drugmakers. The deal focused on lowering costs for obesity medications. An executive was speaking when the attendee collapsed.
Who was incorrectly identified as the person who fainted?
Online users initially named Gordon Findlay. He is a Global Brand Director for Novo Nordisk. The company confirmed he was not in the Oval Office.
How did the White House respond to the incident?
The White House Medical Unit acted immediately. Press Secretary Karoline Leavitter confirmed their quick action. She stated the gentleman was okay after treatment.
Did the press conference continue?
Yes, the event was temporarily suspended. Officials later confirmed the press conference would resume shortly. The policy announcement was completed.
Which companies were involved in the Oval Office deal?
The agreement featured Eli Lilly and Novo Nordisk. The deal aimed to expand coverage for their popular weight-loss drugs. Price reduction was a key goal.
iNews covers the latest and most impactful stories across
entertainment,
business,
sports,
politics, and
technology,
from AI breakthroughs to major global developments. Stay updated with the trends shaping our world. For news tips, editorial feedback, or professional inquiries, please email us at
[email protected].
Get the latest news and Breaking News first by following us on
Google News,
Twitter,
Facebook,
Telegram
, and subscribe to our
YouTube channel.



